BioCentury
ARTICLE | Clinical News

Pfizer preclinical data

November 11, 2002 8:00 AM UTC

Researchers published in Nature that in a mouse model of MS, atorvastatin treatment significantly ameliorated symptoms when given either before or after disease onset (p<0.001). The researchers sugges...